.jpg)
.jpg)
.jpg)
Barnes & Noble Shares Soar After Investor Discusses Sale with Founder
07 Sep, 2018
Biogen Stock Price Jump 40% After FDA Approves Alzheimer’s Drug
Biogen Inc. (NASDAQ: BIIB) Alzheimer’s drug aducanumab or “Aduhelm” was approved by the Food and Drug Administration (FDA) this morning. Aduhelm is the first drug cleared by the FDA to help fight Alzheimer’s in almost 20 year..
Biogen Reports Positive Results on Alzheimer's Trial, Shares Soar
Biogen Inc. (NASDAQ: BIIB) announced today that the outcome of its large clinical trial consisting of 856 patients regarding an Alzheimer’s drug produced positive results. Together with its Japanese partner, Eisai Co., the experimental dr..
Biogen Misses Earnings but Tops Revenue Estimates
Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter financial results for fiscal year 2017. The U.S. drug-maker fell short on earnings estimates, but topped revenue estimates, sending shares 3 percent higher during Thursday’s pre-marke..
@Newsletter
Sign Up for Weekly UpdatesOpt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!
No articles found.
.jpg){kind=small}
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).